David Mirsky
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 51 | 2026 | 3863 | 3.440 |
Why?
| | Prenatal Diagnosis | 9 | 2026 | 195 | 2.250 |
Why?
| | Hydrocephalus | 6 | 2023 | 111 | 2.170 |
Why?
| | Brain Neoplasms | 12 | 2026 | 1318 | 1.440 |
Why?
| | Stroke | 14 | 2022 | 1256 | 1.420 |
Why?
| | Craniocerebral Trauma | 6 | 2025 | 176 | 1.420 |
Why?
| | Child Abuse | 8 | 2025 | 551 | 1.410 |
Why?
| | Brain | 16 | 2026 | 2933 | 1.380 |
Why?
| | Neuroimaging | 10 | 2024 | 289 | 1.300 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2020 | 34 | 1.140 |
Why?
| | Craniopharyngioma | 6 | 2025 | 77 | 1.080 |
Why?
| | Nervous System Malformations | 3 | 2025 | 47 | 1.040 |
Why?
| | Child | 62 | 2026 | 22633 | 1.020 |
Why?
| | Tomography, X-Ray Computed | 13 | 2024 | 2730 | 1.000 |
Why?
| | Central Nervous System Neoplasms | 3 | 2025 | 173 | 0.980 |
Why?
| | Neural Tube Defects | 2 | 2018 | 65 | 0.940 |
Why?
| | Pituitary Neoplasms | 5 | 2025 | 190 | 0.870 |
Why?
| | Fetus | 6 | 2022 | 803 | 0.870 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.860 |
Why?
| | Intracranial Hemorrhages | 3 | 2026 | 100 | 0.840 |
Why?
| | Retrospective Studies | 39 | 2026 | 17066 | 0.840 |
Why?
| | Head and Neck Neoplasms | 3 | 2022 | 558 | 0.820 |
Why?
| | Placenta Accreta | 1 | 2024 | 29 | 0.810 |
Why?
| | Infant | 26 | 2026 | 10034 | 0.740 |
Why?
| | Megalencephaly | 1 | 2022 | 19 | 0.740 |
Why?
| | Contrast Media | 5 | 2025 | 488 | 0.740 |
Why?
| | Pediatrics | 6 | 2025 | 1114 | 0.730 |
Why?
| | Circle of Willis | 1 | 2022 | 7 | 0.730 |
Why?
| | Humans | 114 | 2026 | 144759 | 0.720 |
Why?
| | Epidermal Cyst | 1 | 2022 | 12 | 0.720 |
Why?
| | Child, Preschool | 34 | 2026 | 11787 | 0.720 |
Why?
| | Dermoid Cyst | 1 | 2022 | 14 | 0.720 |
Why?
| | Nasal Obstruction | 1 | 2021 | 26 | 0.660 |
Why?
| | Neck | 4 | 2022 | 108 | 0.650 |
Why?
| | Infant, Newborn, Diseases | 2 | 2019 | 113 | 0.650 |
Why?
| | Central Nervous System Infections | 2 | 2018 | 35 | 0.640 |
Why?
| | Ependymoma | 1 | 2022 | 176 | 0.630 |
Why?
| | Gadolinium DTPA | 2 | 2019 | 68 | 0.630 |
Why?
| | Ultrasonography, Prenatal | 4 | 2025 | 294 | 0.630 |
Why?
| | Temporal Lobe | 1 | 2019 | 104 | 0.590 |
Why?
| | Cavernous Sinus Thrombosis | 2 | 2015 | 8 | 0.580 |
Why?
| | Anatomic Landmarks | 1 | 2018 | 31 | 0.570 |
Why?
| | Thrombosis | 1 | 2022 | 393 | 0.560 |
Why?
| | Medical Oncology | 3 | 2025 | 332 | 0.560 |
Why?
| | Female | 60 | 2026 | 78271 | 0.540 |
Why?
| | Occipital Lobe | 1 | 2017 | 26 | 0.530 |
Why?
| | Fetal Diseases | 2 | 2026 | 191 | 0.520 |
Why?
| | Pregnancy | 16 | 2026 | 7190 | 0.510 |
Why?
| | Spinal Cord | 2 | 2021 | 380 | 0.500 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 120 | 0.490 |
Why?
| | Facial Injuries | 1 | 2016 | 24 | 0.490 |
Why?
| | Artificial Intelligence | 3 | 2025 | 365 | 0.490 |
Why?
| | Frontal Lobe | 1 | 2017 | 160 | 0.480 |
Why?
| | Brain Diseases | 2 | 2020 | 152 | 0.480 |
Why?
| | Head | 2 | 2019 | 120 | 0.470 |
Why?
| | Spinal Injuries | 3 | 2022 | 58 | 0.470 |
Why?
| | Carotid Stenosis | 2 | 2015 | 102 | 0.470 |
Why?
| | Tissue Adhesions | 1 | 2015 | 34 | 0.470 |
Why?
| | Lymphatic Abnormalities | 2 | 2012 | 20 | 0.460 |
Why?
| | Societies, Medical | 6 | 2022 | 887 | 0.460 |
Why?
| | Cerebral Infarction | 1 | 2015 | 47 | 0.450 |
Why?
| | Craniofacial Abnormalities | 2 | 2012 | 76 | 0.440 |
Why?
| | Hypothalamus | 1 | 2015 | 153 | 0.440 |
Why?
| | Central Nervous System Diseases | 1 | 2015 | 74 | 0.440 |
Why?
| | Male | 44 | 2026 | 72315 | 0.410 |
Why?
| | Prevalence | 5 | 2024 | 2834 | 0.400 |
Why?
| | Infant, Newborn | 14 | 2022 | 6429 | 0.390 |
Why?
| | Dandy-Walker Syndrome | 2 | 2023 | 7 | 0.390 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2023 | 225 | 0.380 |
Why?
| | Stomatognathic Diseases | 1 | 2012 | 4 | 0.370 |
Why?
| | Goiter | 1 | 2012 | 5 | 0.370 |
Why?
| | Adolescent | 23 | 2025 | 22428 | 0.370 |
Why?
| | Diagnosis, Differential | 8 | 2025 | 1489 | 0.350 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2025 | 121 | 0.350 |
Why?
| | Meningomyelocele | 2 | 2022 | 61 | 0.350 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2025 | 285 | 0.340 |
Why?
| | Magnetic Resonance Angiography | 3 | 2019 | 251 | 0.330 |
Why?
| | Brain Ischemia | 3 | 2022 | 358 | 0.330 |
Why?
| | Glioma | 2 | 2026 | 425 | 0.330 |
Why?
| | Sinusitis | 3 | 2018 | 228 | 0.320 |
Why?
| | Sacrum | 3 | 2018 | 78 | 0.310 |
Why?
| | Infarction, Middle Cerebral Artery | 3 | 2022 | 41 | 0.300 |
Why?
| | Hypothalamic Diseases | 2 | 2022 | 17 | 0.300 |
Why?
| | Cerebellum | 3 | 2026 | 223 | 0.280 |
Why?
| | Emergency Medical Services | 1 | 2015 | 696 | 0.280 |
Why?
| | Evidence-Based Medicine | 6 | 2022 | 732 | 0.280 |
Why?
| | Anorectal Malformations | 2 | 2021 | 113 | 0.280 |
Why?
| | Postoperative Complications | 2 | 2018 | 2919 | 0.270 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 93 | 0.270 |
Why?
| | Prenatal Care | 4 | 2022 | 307 | 0.270 |
Why?
| | Placenta | 2 | 2025 | 780 | 0.270 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 227 | 0.260 |
Why?
| | Gestational Age | 4 | 2025 | 975 | 0.250 |
Why?
| | Teratoma | 2 | 2019 | 120 | 0.250 |
Why?
| | Muscular Diseases | 2 | 2020 | 108 | 0.250 |
Why?
| | Cerebrovascular Disorders | 2 | 2020 | 103 | 0.240 |
Why?
| | Brain Injuries, Traumatic | 2 | 2025 | 441 | 0.240 |
Why?
| | Brain Injuries | 2 | 2025 | 507 | 0.240 |
Why?
| | Cerebellar Diseases | 1 | 2026 | 27 | 0.230 |
Why?
| | Priapism | 1 | 2005 | 10 | 0.230 |
Why?
| | Disease Progression | 3 | 2025 | 2847 | 0.230 |
Why?
| | Penis | 1 | 2005 | 32 | 0.230 |
Why?
| | Chloroquine | 2 | 2017 | 53 | 0.230 |
Why?
| | Hematoma, Subdural | 2 | 2022 | 20 | 0.230 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.220 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 30 | 0.220 |
Why?
| | Brain Edema | 1 | 2025 | 62 | 0.220 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2024 | 12 | 0.220 |
Why?
| | Malformations of Cortical Development | 1 | 2024 | 19 | 0.210 |
Why?
| | Placental Circulation | 1 | 2025 | 70 | 0.210 |
Why?
| | Nasal Septum | 1 | 2024 | 30 | 0.210 |
Why?
| | Mastectomy, Segmental | 2 | 2001 | 108 | 0.210 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2194 | 0.200 |
Why?
| | Clinical Trials as Topic | 2 | 2025 | 1053 | 0.200 |
Why?
| | Microvessels | 1 | 2025 | 99 | 0.200 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 154 | 0.200 |
Why?
| | Tumor Burden | 1 | 2024 | 319 | 0.200 |
Why?
| | Phenotype | 4 | 2024 | 3162 | 0.190 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2020 | 44 | 0.190 |
Why?
| | Autophagy | 2 | 2017 | 286 | 0.190 |
Why?
| | Nerve Net | 1 | 2026 | 285 | 0.190 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 242 | 0.190 |
Why?
| | Physical Abuse | 1 | 2023 | 40 | 0.190 |
Why?
| | Neck Injuries | 1 | 2022 | 21 | 0.190 |
Why?
| | Surface Plasmon Resonance | 1 | 2022 | 89 | 0.190 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2022 | 27 | 0.180 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 248 | 0.180 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.180 |
Why?
| | Pyrimidinones | 1 | 2023 | 126 | 0.180 |
Why?
| | Cysts | 1 | 2022 | 111 | 0.170 |
Why?
| | Indoles | 2 | 2017 | 501 | 0.170 |
Why?
| | Sulfonamides | 2 | 2017 | 580 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2023 | 112 | 0.170 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 75 | 0.170 |
Why?
| | Sensitivity and Specificity | 3 | 2025 | 1985 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 265 | 0.170 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 103 | 0.170 |
Why?
| | Pyridones | 1 | 2023 | 199 | 0.170 |
Why?
| | White Matter | 1 | 2023 | 153 | 0.170 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2001 | 88 | 0.170 |
Why?
| | Neuroblastoma | 1 | 2022 | 174 | 0.170 |
Why?
| | Pituitary Diseases | 1 | 2020 | 20 | 0.170 |
Why?
| | Breast | 1 | 2001 | 158 | 0.170 |
Why?
| | Vitamin B 12 | 1 | 2021 | 127 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 162 | 0.170 |
Why?
| | Epilepsy | 2 | 2016 | 376 | 0.170 |
Why?
| | Sutures | 1 | 2021 | 64 | 0.160 |
Why?
| | Nasal Cavity | 1 | 2021 | 62 | 0.160 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2020 | 36 | 0.160 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2020 | 23 | 0.160 |
Why?
| | Arnold-Chiari Malformation | 1 | 2020 | 29 | 0.160 |
Why?
| | Seizures | 3 | 2024 | 460 | 0.160 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 10 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.160 |
Why?
| | Mammography | 1 | 2001 | 166 | 0.160 |
Why?
| | Leigh Disease | 1 | 2020 | 22 | 0.160 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.160 |
Why?
| | Tyrosine | 1 | 2020 | 222 | 0.160 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 91 | 0.150 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 824 | 0.150 |
Why?
| | Spasms, Infantile | 1 | 2021 | 136 | 0.150 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 48 | 0.150 |
Why?
| | RNA, Transfer | 1 | 2020 | 144 | 0.150 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 211 | 0.150 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.150 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.150 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2020 | 78 | 0.150 |
Why?
| | Taenia solium | 1 | 2018 | 5 | 0.150 |
Why?
| | United States | 11 | 2025 | 15966 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 587 | 0.140 |
Why?
| | Neurocysticercosis | 1 | 2018 | 8 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2025 | 1137 | 0.140 |
Why?
| | Ilium | 1 | 2018 | 30 | 0.140 |
Why?
| | Foramen Magnum | 1 | 2018 | 10 | 0.140 |
Why?
| | Occipital Bone | 1 | 2018 | 18 | 0.140 |
Why?
| | Sphenoid Bone | 1 | 2018 | 15 | 0.140 |
Why?
| | Radiology | 1 | 2020 | 174 | 0.140 |
Why?
| | Skull Base | 1 | 2018 | 54 | 0.140 |
Why?
| | Developmental Disabilities | 2 | 2024 | 281 | 0.140 |
Why?
| | Soft Tissue Neoplasms | 1 | 2019 | 127 | 0.140 |
Why?
| | Reference Values | 1 | 2019 | 797 | 0.140 |
Why?
| | Area Under Curve | 1 | 2018 | 330 | 0.130 |
Why?
| | Adult | 12 | 2026 | 40449 | 0.130 |
Why?
| | Toxoplasmosis | 1 | 2018 | 43 | 0.130 |
Why?
| | Fecal Incontinence | 1 | 2018 | 91 | 0.130 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.130 |
Why?
| | Olfaction Disorders | 1 | 2018 | 70 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1560 | 0.130 |
Why?
| | Adenoidectomy | 1 | 2018 | 81 | 0.130 |
Why?
| | Epilepsies, Partial | 1 | 2018 | 61 | 0.130 |
Why?
| | Radiation Dosage | 1 | 2019 | 192 | 0.130 |
Why?
| | Coccyx | 1 | 2017 | 4 | 0.130 |
Why?
| | Central Nervous System | 2 | 2022 | 281 | 0.130 |
Why?
| | Common Data Elements | 1 | 2017 | 15 | 0.130 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2018 | 156 | 0.130 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 9 | 0.130 |
Why?
| | Herpes Simplex | 1 | 2018 | 98 | 0.130 |
Why?
| | Fetal Movement | 1 | 2016 | 7 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 58 | 0.130 |
Why?
| | Fetal Monitoring | 1 | 2016 | 20 | 0.130 |
Why?
| | Olfactory Bulb | 1 | 2018 | 97 | 0.120 |
Why?
| | Diazepam | 1 | 2016 | 33 | 0.120 |
Why?
| | Mitochondria | 2 | 2020 | 984 | 0.120 |
Why?
| | ROC Curve | 1 | 2018 | 614 | 0.120 |
Why?
| | Spondylolysis | 1 | 2016 | 8 | 0.120 |
Why?
| | Organ Size | 1 | 2017 | 463 | 0.120 |
Why?
| | Anti-Anxiety Agents | 1 | 2016 | 45 | 0.120 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 323 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 189 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 583 | 0.120 |
Why?
| | Osteomyelitis | 1 | 2018 | 143 | 0.120 |
Why?
| | Balamuthia mandrillaris | 1 | 2015 | 4 | 0.120 |
Why?
| | Amebiasis | 1 | 2015 | 5 | 0.120 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 124 | 0.120 |
Why?
| | Genome, Microbial | 1 | 2015 | 7 | 0.120 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 206 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 780 | 0.120 |
Why?
| | Third Ventricle | 1 | 2015 | 16 | 0.120 |
Why?
| | Intracranial Thrombosis | 1 | 2015 | 19 | 0.120 |
Why?
| | Fracture Fixation | 1 | 2016 | 79 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 168 | 0.120 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 29 | 0.120 |
Why?
| | Hamartoma | 1 | 2015 | 29 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 35 | 0.110 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 111 | 0.110 |
Why?
| | Headache | 3 | 2023 | 150 | 0.110 |
Why?
| | Eye Infections, Fungal | 1 | 2015 | 19 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 129 | 0.110 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 11 | 0.110 |
Why?
| | Orbital Cellulitis | 1 | 2015 | 17 | 0.110 |
Why?
| | Onchocerciasis | 1 | 2015 | 8 | 0.110 |
Why?
| | Pyridoxine | 1 | 2015 | 37 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2015 | 40 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Spinal Cord Diseases | 1 | 2015 | 41 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Eye Infections, Bacterial | 1 | 2015 | 44 | 0.110 |
Why?
| | Paralysis | 1 | 2015 | 67 | 0.110 |
Why?
| | Emergencies | 1 | 2015 | 175 | 0.110 |
Why?
| | Cranial Nerve Diseases | 1 | 2014 | 43 | 0.110 |
Why?
| | Paraplegia | 1 | 2014 | 61 | 0.110 |
Why?
| | Cohort Studies | 3 | 2024 | 5960 | 0.110 |
Why?
| | Software | 1 | 2020 | 690 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2014 | 49 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 253 | 0.100 |
Why?
| | Glasgow Coma Scale | 2 | 2025 | 213 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 252 | 0.100 |
Why?
| | Perioperative Care | 1 | 2016 | 231 | 0.100 |
Why?
| | Breast Neoplasms | 3 | 2001 | 2452 | 0.100 |
Why?
| | Encephalitis | 1 | 2015 | 139 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 881 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 2017 | 284 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1539 | 0.100 |
Why?
| | Fetal Therapies | 1 | 2014 | 47 | 0.100 |
Why?
| | Arginine | 1 | 2015 | 262 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 64 | 0.100 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 138 | 0.100 |
Why?
| | Enterovirus D, Human | 1 | 2014 | 87 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 965 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2145 | 0.090 |
Why?
| | Lysine | 1 | 2015 | 302 | 0.090 |
Why?
| | Prognosis | 4 | 2026 | 4282 | 0.090 |
Why?
| | Otitis Media | 1 | 2015 | 181 | 0.090 |
Why?
| | Pharyngeal Diseases | 1 | 2012 | 16 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2016 | 535 | 0.090 |
Why?
| | Logistic Models | 1 | 2017 | 2117 | 0.090 |
Why?
| | Enterovirus Infections | 1 | 2014 | 173 | 0.090 |
Why?
| | Cranial Fossa, Posterior | 2 | 2022 | 20 | 0.090 |
Why?
| | Amino Acids | 1 | 2015 | 521 | 0.080 |
Why?
| | HIV Infections | 2 | 2018 | 3154 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3604 | 0.080 |
Why?
| | Incidence | 1 | 2017 | 2879 | 0.080 |
Why?
| | Mutation | 5 | 2021 | 4089 | 0.080 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 62 | 0.080 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 336 | 0.080 |
Why?
| | Young Adult | 4 | 2024 | 14105 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 315 | 0.080 |
Why?
| | Risk Factors | 5 | 2025 | 10779 | 0.080 |
Why?
| | Physical Examination | 2 | 2023 | 239 | 0.070 |
Why?
| | Ultrasonography | 2 | 2021 | 770 | 0.070 |
Why?
| | Brain Stem | 2 | 2023 | 95 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1907 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3409 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2025 | 11679 | 0.070 |
Why?
| | Cervical Vertebrae | 2 | 2022 | 158 | 0.070 |
Why?
| | Cerebrospinal Fluid | 2 | 2018 | 88 | 0.060 |
Why?
| | Pons | 1 | 2026 | 33 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2925 | 0.060 |
Why?
| | Family | 2 | 2021 | 679 | 0.060 |
Why?
| | Research Design | 2 | 2025 | 1135 | 0.060 |
Why?
| | Recurrence | 2 | 2022 | 1135 | 0.060 |
Why?
| | Thalamus | 1 | 2026 | 125 | 0.050 |
Why?
| | Spinal Fractures | 1 | 2005 | 73 | 0.050 |
Why?
| | Age Factors | 2 | 2025 | 3333 | 0.050 |
Why?
| | Angiography | 1 | 2005 | 208 | 0.050 |
Why?
| | Genetic Counseling | 1 | 2025 | 81 | 0.050 |
Why?
| | Drug Synergism | 2 | 2017 | 357 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2022 | 5408 | 0.050 |
Why?
| | Observer Variation | 1 | 2025 | 355 | 0.050 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2024 | 18 | 0.050 |
Why?
| | Endarterectomy, Carotid | 1 | 2004 | 60 | 0.050 |
Why?
| | Patient Care Planning | 1 | 2025 | 169 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 184 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2025 | 203 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 222 | 0.050 |
Why?
| | Europe | 1 | 2025 | 412 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 329 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2004 | 207 | 0.050 |
Why?
| | Radiography, Interventional | 1 | 2004 | 130 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 488 | 0.050 |
Why?
| | Algorithms | 2 | 2022 | 1837 | 0.050 |
Why?
| | Prospective Studies | 4 | 2021 | 7990 | 0.050 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 141 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 16 | 0.050 |
Why?
| | Intellectual Disability | 1 | 2024 | 175 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2025 | 600 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 69 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 56 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 195 | 0.050 |
Why?
| | Synapses | 1 | 2026 | 439 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 26 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.040 |
Why?
| | Counseling | 1 | 2025 | 408 | 0.040 |
Why?
| | Wounds, Gunshot | 1 | 2005 | 258 | 0.040 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 24 | 0.040 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 42 | 0.040 |
Why?
| | Time and Motion Studies | 1 | 2001 | 28 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 202 | 0.040 |
Why?
| | Biopsy | 2 | 2001 | 1075 | 0.040 |
Why?
| | Retinal Hemorrhage | 1 | 2021 | 21 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 147 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 151 | 0.040 |
Why?
| | Radiography | 1 | 2023 | 844 | 0.040 |
Why?
| | Neuroradiography | 1 | 2020 | 5 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 249 | 0.040 |
Why?
| | Stents | 1 | 2004 | 556 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2001 | 139 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 60 | 0.040 |
Why?
| | Anal Canal | 1 | 2021 | 102 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 149 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 45 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 116 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 199 | 0.040 |
Why?
| | Sacrococcygeal Region | 1 | 2019 | 6 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 210 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 304 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 35 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 69 | 0.040 |
Why?
| | Antibodies, Helminth | 1 | 2018 | 6 | 0.040 |
Why?
| | Diaper Rash | 1 | 2018 | 5 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 63 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 73 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 880 | 0.040 |
Why?
| | Kallmann Syndrome | 1 | 2018 | 7 | 0.040 |
Why?
| | Hemispherectomy | 1 | 2018 | 2 | 0.040 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2018 | 20 | 0.030 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2018 | 44 | 0.030 |
Why?
| | Urinary Incontinence | 1 | 2018 | 64 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2018 | 316 | 0.030 |
Why?
| | Mastectomy | 1 | 1999 | 162 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 95 | 0.030 |
Why?
| | Weight Gain | 1 | 2022 | 556 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2017 | 2496 | 0.030 |
Why?
| | Choice Behavior | 1 | 1999 | 177 | 0.030 |
Why?
| | Meningitis | 1 | 2018 | 80 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1054 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 3540 | 0.030 |
Why?
| | Informed Consent | 1 | 1999 | 198 | 0.030 |
Why?
| | Constipation | 1 | 2018 | 98 | 0.030 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 6 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 338 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 549 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2020 | 582 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 609 | 0.030 |
Why?
| | Trauma Centers | 1 | 2019 | 462 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1627 | 0.030 |
Why?
| | Eosinophilia | 1 | 2018 | 221 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 551 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 316 | 0.030 |
Why?
| | Rhinitis | 1 | 2018 | 171 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1087 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 2016 | 66 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3671 | 0.030 |
Why?
| | Oximetry | 1 | 2016 | 126 | 0.030 |
Why?
| | Mucormycosis | 1 | 2015 | 19 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 103 | 0.030 |
Why?
| | Diet Therapy | 1 | 2015 | 37 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 1095 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 532 | 0.030 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2015 | 90 | 0.030 |
Why?
| | Data Collection | 1 | 2017 | 633 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 202 | 0.030 |
Why?
| | Metagenomics | 1 | 2015 | 181 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 1999 | 780 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1098 | 0.020 |
Why?
| | Body Mass Index | 1 | 2022 | 2438 | 0.020 |
Why?
| | Venous Thrombosis | 1 | 2015 | 194 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1953 | 0.020 |
Why?
| | Streptococcal Infections | 1 | 2015 | 168 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 406 | 0.020 |
Why?
| | Mass Screening | 1 | 2001 | 1347 | 0.020 |
Why?
| | Branchial Region | 1 | 2012 | 37 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 1030 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1047 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 248 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 611 | 0.020 |
Why?
| | Visual Acuity | 1 | 2015 | 489 | 0.020 |
Why?
| | Animals | 3 | 2021 | 38058 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2115 | 0.020 |
Why?
| | Time Factors | 2 | 2019 | 7173 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5868 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 422 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 388 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2015 | 576 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1325 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4564 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3185 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 710 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1795 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1337 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1109 | 0.020 |
Why?
| | Aged | 4 | 2019 | 25913 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3077 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2005 | 21 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6048 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 183 | 0.010 |
Why?
| | Middle Aged | 3 | 2019 | 35875 | 0.010 |
Why?
| | Canada | 1 | 2001 | 428 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2005 | 8265 | 0.010 |
Why?
| | Disease Management | 1 | 1999 | 645 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1999 | 885 | 0.010 |
Why?
|
|
Mirsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|